Expression of HERV-K correlates with status of MEKERK and p16INK4ACDK4 pathways in melanoma cells

Cancer Investigation

Volumn 28, Issue 10, 2010, Pages 1031-1037

  Li, Zhongwu ^a,c   Sheng, Tao ^b   Wan, Xiaohua ^a,d   Liu, Tianshuang ^b   Wu, Hai ^b   Dong, Jianli ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

HERV K; MEKERK; Melanoma; p16INK4ACDK4

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GAG PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS K; MAJOR CLINICAL STUDY; MELANOMA CELL; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS EXPRESSION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE KINASE KINASES; MELANOMA; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 78649300911     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.512604     Document Type: Article

References (29)

1. Li, J.; Xu, M.; Yang, Z.; Li, A.; Dong, J. Simultaneous inhibition of MEK and CDK4 leads to potent apoptosis in human melanoma cells. Cancer Invest 2010, 28, 350-356.
2. Rotolo, S.; Diotti, R.; Gordon, R. E.; Qiao, R. F.; Yao, Z.; Phelps, R. G.; Dong, J. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells. Int J Cancer 2005, 115, 164-169.
3. Zhao, Y.; Zhang, Y.; Yang, Z.; Li, A.; Dong, J. Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis. Biochem Biophys Res Commun 2008, 370, 509-513.
4. Muster, T.; Waltenberger, A.; Grassauer, A.; Hirschl, S.; Caucig, P.; Romirer, I.; Fodinger, D.; Seppele, H.; Schanab, O.; Magin-Lachmann, C.; Lower, R.; Jansen, B.; Pehamberger, H.; Wolff, K. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003, 63, 8735-8741.
5. Voisset, C.; Weiss, R. A.; Griffiths, D. J., Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev 2008, 72, 157-196.
6. Singh, S.; Kaye, S.; Gore, M. E.; McClure, M. O.; Bunker, C. B. The role of human endogenous retroviruses in melanoma. Br J Dermatol 2009, 161, 1225-1231.
7. Ahn, K.; Kim, H. S. Structural and quantitative expression analyses of HERV gene family in human tissues. Mol Cells 2009, 28, 99-103.
8. Beimforde, N.; Hanke, K.; Ammar, I.; Kurth, R.; Bannert, N. Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology 2008, 371, 216-225.
9. Turner, G.; Barbulescu, M.; Su, M.; Jensen-Seaman, M. I.; Kidd, K. K.; Lenz, J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 2001, 11, 1531-1535.
10. Lower, R.; Boller, K.; Hasenmaier, B.; Korbmacher, C.; Muller-Lantzsch, N.; Lower, J.; Kurth, R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A 1993, 90, 4480-4484.
11. Seifarth, W.; Frank, O.; Zeilfelder, U.; Spiess, B.; Greenwood, A. D.; Hehlmann, R.; Leib-Mosch, C. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol 2005, 79, 341-352.
12. Kalter, S. S.; Helmke, R. J.; Heberling, R. L.; Panigel, M.; Fowler, A. K.; Strickland, J. E.; Hellman, A. Brief communication: C-type particles in normal human placentas. J Natl Cancer Inst 1973, 50, 1081-1084.
13. Pothlichet, J.; Mangeney, M.; Heidmann, T. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int J Cancer 2006, 119, 1869-1877.
14. Tchenio, T.; Heidmann, T. Defective retroviruses can disperse in the human genome by intracellular transposition. J Virol 1991, 65, 2113-2118.
15. Mangeney, M.; Pothlichet, J.; Renard, M.; Ducos, B.; Heidmann, T. Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res 2005, 65, 2588-2591.
16. Oricchio, E.; Sciamanna, I.; Beraldi, R.; Tolstonog, G. V.; Schumann, G. G.; Spadafora, C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 2007, 26, 4226-4233.
17. Serafino, A.; Balestrieri, E.; Pierimarchi, P.; Matteucci, C.; Moroni, G.; Oricchio, E.; Rasi, G.; Mastino, A.; Spadafora, C.; Garaci, E.; Vallebona, P. S. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res 2009, 315, 849-862.
18. Mettling, C.; Desmetz, C.; Fiser, A. L.; Reant, B.; Corbeau, P.; Lin, Y. L. Galphai protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription. AIDS 2008, 22, 1569-1576.
19. Richmond-Sinclair, N. M.; Lee, E.; Cummings, M. C.; Williamson, R.; Muller, K.; Green, A. C.; Hayward, N. K.; Whiteman, D. C. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas. Melanoma Res 2008, 18, 336-345.
20. Ghiorzo, P.; Villaggio, B.; Sementa, A. R.; Hansson, J.; Platz, A.; Nicolo, G.; Spina, B.; Canepa, M.; Palmer, J. M.; Hayward, N. K.; Bianchi-Scarra, G. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients. Hum Pathol 2004, 35, 25-33.
21. Buscher, K.; Hahn, S.; Hofmann, M.; Trefzer, U.; Ozel, M.; Sterry, W.; Lower, J.; Lower, R.; Kurth, R.; Denner, J. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res 2006, 16, 223-234.
22. Buscher, K.; Trefzer, U.; Hofmann, M.; Sterry, W.; Kurth, R.; Denner, J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 2005, 65, 4172-4180.
23. Romano, C. M.; Ramalho, R. F.; Zanotto, P. M. Tempo and mode of ERV-K evolution in human and chimpanzee genomes. Arch Virol 2006, 151, 2215-2228.
24. Hirschl, S.; Schanab, O.; Seppele, H.; Waltenberger, A.; Humer, J.; Wolff, K.; Pehamberger, H.; Muster, T. Sequence variability of retroviral particles derived from human melanoma cells melanomaassociated retrovirus. Virus Res 2007, 123, 211-215.
25. Taruscio, D.; Mantovani, A. Factors regulating endogenous retroviral sequences in human and mouse. Cytogenet Genome Res 2004, 105, 351-362.
26. Lavie, L.; Kitova, M.; Maldener, E.; Meese, E.; Mayer, J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K (HML-2). J Virol 2005, 79, 876-883.
27. Montoya-Durango, D. E.; Liu, Y.; Teneng, I.; Kalbfleisch, T.; Lacy, M. E.; Steffen, M. C.; Ramos, K. S. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res 2009, 665, 20-28.
28. Cui, Y.; Borysova, M. K.; Johnson, J. O.; Guadagno, T. M. Oncogenic B-Raf (V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells. Cancer Res 2010, 70, 675-684.
29. Henkel, J. Attacking AIDS with a 'cocktail' therapy? FDA Consum 1999, 33, 12-17.